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INTRODUCTION:  Multiple  myeloma  is a  monoclonal,  immunoproliferative  plasma-cell  neoplasm  of the
B  lymphoid  cells.  Extramedullary  plasmacytoma  is a  type  of plasma-cell  neoplasm  that  can  present
as  a primary  tumour  or  secondary  to another  plasma-cell  neoplasm,  such  as  multiple  myeloma.  Sec-
ondary  extramedullary  plasmacytoma  is  usually  noted  in  the  advanced  stages  of the  disease  with  ileum
involvement  being  very  rare.
PRESENTATION OF  CASE:  We  report  a rare case  of a 58-year-old  man,  with  known  multiple  myeloma,  re-
presenting  with  evidence  of  small  bowel  obstruction,  secondary  to  an  intussusception  due to  a malignant
plasma  cell  deposit,  which  was  successfully  resected  at laparotomy.  Previous  two  similar  admissions,
prior  to  this  index  admission,  failed  to arrive  at this  difﬁcult  rare  diagnosis.
DISCUSSION: Primary  and  secondary  extramedullary  plasmacytoma  mainly  affects  the  upper  aero-
digestive  tract.  Involvement  of  the  ileum,  as in this  case,  is a rare  complication.
Prognosis of  secondary  extramedullary  plasmacytoma  affecting  the  gastrointestinal  tracts  is  unknown,
due  to the  small  number  of  cases  reported  in  the literature,  but  suggestive  of  a poor  prognosis.  The  role
of  surgery  is  often  palliative  to deal  with  resolvable  life-threatening  emergencies  and where  possible  to
prolong  life.
CONCLUSION:  The  case  adds  to  the  current  literature  of  the rare event  of  visceral  secondary  extramedullary
plasmacytoma  involving  the gastrointestinal  tract,  in  the  course  of  multiple  myeloma  and  highlights  the
need  for  a high  index  of  suspicion  for  such  uncommon  complications,  to  avoid  delay  in  diagnosis  and
treatment.
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. Introduction
Extramedullary plasmacytoma (EMP) is a type of plasma cell
eoplasm (PCN) that can present as a primary tumour or secondary
o another PCN, such as multiple myeloma (MM).  Most reports indi-
ate that EMP  commonly affects the upper respiratory tract and
ral cavity.1 Gastrointestinal manifestations are rare, particularly
nvolvement of the small intestine. Almost all cases reported in the
nglish language literature are primary in nature.2 We  report a rare
nd unusual case of a patient with a relapse of MM,  presenting
ith small bowel obstruction due to intussusception resulting from
econdary EMP, who underwent a small bowel resection.
.  Case presentationBS,  a 58-year-old man  presented to the haematology day case
nit with nausea, vomiting, abdominal distension and absolute
onstipation of two days duration. A week earlier he had been
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brieﬂy admitted for three days with similar symptoms during
his ﬁfth cycle of lenolidamide and dexamethasone, with evidence
of small bowel dilatation on abdominal radiograph. During that
admission he was  presumed to have gastroenteritis and treated
conservatively with ﬂuids and anti-emetics.
BS was  diagnosed two  years previously with MM,  with mono-
clonal bands of IgA lambda light chains and multiple lytic lesions on
radiological assessment. He was initially treated with cyclophos-
phomide, thalidomide and dexamethasone with adjuvant high
dose melphalan and an autologous stem cell transplant after six
months. BS relapsed with monoclonal bands of IgG Kappa six
months after the transplant.
On  two occasions, one year and also sixth months before this
index admission, BS had similar symptoms, which resolved spon-
taneously at home and did not present to the medical services. On
his index admission, the ﬁndings included anaemia (Haemoglobin
of 11.1 g/dL) and abdominal distension. Small bowel dilatation was
conﬁrmed on abdominal X-rays. Due to failure to improve, an
abdominal computed tomography (CT) scan was  performed which
Open access under CC BY-NC-ND license.conﬁrmed a small bowel obstruction with an ileo-ileal intussus-
ception in the distal ileum (Fig. 1).
At emergency laparotomy an ileo-ileal intussusception was con-
ﬁrmed as well as a nodular mass in the mesentery at the apex of
Y-NC-ND license. 
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cFig. 1. Abdominal CT scan showing small bowel intussusception.
he intussusception (Fig. 2). A wedge resection of 25 cm of the small
owel and mesentery was carried out, with a hand sewn end-to-end
nastomosis. All other visceral organs appeared normal.
Histology conﬁrmed a nodule of tumour composed of malignant
lasma cells (plasmablastic type) centred within the subserosal and
ubmucosa with focal extension into the lamina propria and ulcer-
tion onto the mucosal surface. The tumour cells showed diffuse
ositive staining for CD138, focal staining with CD79a and lambda
ight chain restriction. The MIB1 proliferation index was  approx-
mately 95%. There was no serosal breach at the leading point of
he intussusception noted. Two out of three identiﬁed mesenteric
odes were positive for tumour. Given the history of MM,  a diag-
osis of secondary EMP  was made.
BS developed hospital acquired pneumonia during the post-
perative period and was discharged home on postoperative
ay eight, with ongoing treatment with lenalidomide and dexa-
ethasone. He was readmitted two months after surgery with
ausea, abdominal distension and electrolyte disturbances. A
epeat abdominal CT scan revealed widespread metastases in the
aracolic gutters, omentum, hepatic serosa and the retroperi-
oneum. He was managed by palliative care and died 13 weeks post
urgery.
ig. 2. Instrument passed into the intussusceptum of an ileo-ileal intussusception
lose  to nodal tumour deposit in the mesentery.PEN  ACCESS
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3. Discussion
This case is unusual on account of its rarity. Haematological
malignancies are the ﬁfth most common type of cancers in the UK
and form a diverse group depending on the origin in the bone mar-
row derived cells. They can be broadly classiﬁed as those neoplasms
of myeloid cell lines, neoplasm of lymphoid cell lines, lymphopro-
liferative disorders and Histiocytic/Dendritic cell neoplasm.
Plasma  cell neoplasm (PCN) is a type of haematological malig-
nancy arising as a result of monoclonal proliferation of plasma cells
(lymphoid cell line) and associated with production of monoclonal
proteins (M Proteins). They include monoclonal gammopathy of
undetermined signiﬁcance (MGUS), solitary plasmacytoma of the
bone (SPB), extramedullary plasmacytoma (EMP), and multiple
myeloma (MM).
EMP  occurs when malignant plasmoblastic clones migrate into
soft tissue and represents only 3–4% of all PCN.1 There are two
major subtypes of EMP  - primary and secondary. In the primary
subtype, it occurs alone in the absence of another PCN, unlike in
the secondary subtype, often with MM.1 Both primary and sec-
ondary EMP  predominantly (>70%) affect the upper aero-digestive
tract (nasopharynx, oropharynx, hypopharynx, larynx, trachea and
oesophagus).2,3
Developing visceral secondary EMP  involving the gastrointesti-
nal tract in the course of MM (a monoclonal, immunoproliferative
PCN  of the B lymphoid cells) is extremely rare – estimated to occur
in 0.9% of cases.4 Only 17 cases of EMP  affecting the ileum have been
reported in the English language literature - almost all primary in
nature,1 with only three previous cases of EMP  secondary to MM
reported.3,5,6 This case falls into the latter category of an even rarer
form of secondary EMP  involving the ileum leading to small bowel
intussusception and obstruction.
This  case highlights the need for a high index of suspicion
for uncommon complications of MM.  It is reasonable to assume
that this patient’s previous symptoms were related to secondary
EMP and should have been considered in his differential diagnosis.
Even so, this can be a diagnostic challenge due to susceptibility of
patients to gastrointestinal infections in the presence of immuno-
suppressive treatment. Furthermore, patients with MM have a
higher risk of pseudo-obstruction of small bowel due to secondary
amyloidosis.7
A primary EMP  managed with local radiotheraphy and/or sur-
gical resection has a good prognosis with a 15-year survival rate of
78%.8 In cases of secondary EMP, radiotheraphy or surgery alone is
insufﬁcient and systemic therapy is required. In younger patients,
the use of immunomodulatory drugs with induction agents in
combination with autologus haematopoietic stem cell transplan-
tation results in higher remission rates and overall survival.2 The
prognosis of secondary EMP  with gastrointestinal involvement is
unknown. However, the small number of cases reported in the
literature indicates a poor prognosis.2,3,5,6,9,10 The role of surgery
in secondary EMP  is often palliative, to deal with resolvable life-
threatening emergencies and where possible to prolong life.
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